Structured observations reveal slow HIV-1 CTL escape.

PubWeight™: 0.88‹?›

🔗 View Article (PMC 4333731)

Published in PLoS Genet on February 02, 2015

Authors

Hannah E Roberts1, Jacob Hurst2, Nicola Robinson3, Helen Brown3, Peter Flanagan1, Laura Vass1, Sarah Fidler4, Jonathan Weber4, Abdel Babiker5, Rodney E Phillips6, Angela R McLean7, John Frater6, SPARTAC trial investigators

Author Affiliations

1: The Peter Medawar Building for Pathogen Research, Nuffield Department of Clinical Medicine, Oxford University, Oxford, United Kingdom.
2: The Peter Medawar Building for Pathogen Research, Nuffield Department of Clinical Medicine, Oxford University, Oxford, United Kingdom; The Institute for Emerging Infections, The Oxford Martin School, Oxford, Oxford United Kingdom.
3: The Peter Medawar Building for Pathogen Research, Nuffield Department of Clinical Medicine, Oxford University, Oxford, United Kingdom; Oxford NIHR Comprehensive Biomedical Research Centre, Oxford, United Kingdom.
4: Division of Medicine, Wright Fleming Institute, Imperial College, London, United Kingdom.
5: Medical Research Council Clinical Trials Unit, London, United Kingdom.
6: The Peter Medawar Building for Pathogen Research, Nuffield Department of Clinical Medicine, Oxford University, Oxford, United Kingdom; The Institute for Emerging Infections, The Oxford Martin School, Oxford, Oxford United Kingdom; Oxford NIHR Comprehensive Biomedical Research Centre, Oxford, United Kingdom.
7: The Institute for Emerging Infections, The Oxford Martin School, Oxford, Oxford United Kingdom; Department of Zoology, Oxford University, Oxford, United Kingdom.

Articles cited by this

Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science (1999) 21.24

A whole-genome association study of major determinants for host control of HIV-1. Science (2007) 15.19

Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature (1991) 10.85

CD8+ T-cell responses to different HIV proteins have discordant associations with viral load. Nat Med (2006) 10.34

HIV evolution: CTL escape mutation and reversion after transmission. Nat Med (2004) 10.21

The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science (2010) 9.61

Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection. Proc Natl Acad Sci U S A (1997) 8.05

Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection. J Exp Med (2009) 7.01

Clustered mutations in HIV-1 gag are consistently required for escape from HLA-B27-restricted cytotoxic T lymphocyte responses. J Exp Med (2001) 6.51

The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection. J Exp Med (2009) 6.22

The immune response during acute HIV-1 infection: clues for vaccine development. Nat Rev Immunol (2009) 5.99

HIV and SIV CTL escape: implications for vaccine design. Nat Rev Immunol (2004) 5.18

Short-course antiretroviral therapy in primary HIV infection. N Engl J Med (2013) 4.82

Selective escape from CD8+ T-cell responses represents a major driving force of human immunodeficiency virus type 1 (HIV-1) sequence diversity and reveals constraints on HIV-1 evolution. J Virol (2005) 4.38

HLA Alleles Associated with Delayed Progression to AIDS Contribute Strongly to the Initial CD8(+) T Cell Response against HIV-1. PLoS Med (2006) 4.19

T cells and viral persistence: lessons from diverse infections. Nat Immunol (2005) 4.12

HLA and AIDS: a cautionary tale. Trends Mol Med (2001) 3.51

Determinants of human immunodeficiency virus type 1 escape from the primary CD8+ cytotoxic T lymphocyte response. J Exp Med (2004) 3.48

Whole genome deep sequencing of HIV-1 reveals the impact of early minor variants upon immune recognition during acute infection. PLoS Pathog (2012) 3.35

Marked epitope- and allele-specific differences in rates of mutation in human immunodeficiency type 1 (HIV-1) Gag, Pol, and Nef cytotoxic T-lymphocyte epitopes in acute/early HIV-1 infection. J Virol (2008) 3.24

Transmission of single HIV-1 genomes and dynamics of early immune escape revealed by ultra-deep sequencing. PLoS One (2010) 3.02

Inefficient cytotoxic T lymphocyte-mediated killing of HIV-1-infected cells in vivo. PLoS Biol (2006) 2.81

Comprehensive analysis of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon-secreting CD8+ T cells in primary HIV-1 infection. J Virol (2003) 2.64

Selection on the human immunodeficiency virus type 1 proteome following primary infection. J Virol (2006) 2.48

Extensive HLA class I allele promiscuity among viral CTL epitopes. Eur J Immunol (2007) 2.10

Vertical T cell immunodominance and epitope entropy determine HIV-1 escape. J Clin Invest (2012) 2.05

Effective T-cell responses select human immunodeficiency virus mutants and slow disease progression. J Virol (2007) 1.98

Loss of viral control in early HIV-1 infection is temporally associated with sequential escape from CD8+ T cell responses and decrease in HIV-1-specific CD4+ and CD8+ T cell frequencies. J Infect Dis (2004) 1.64

Fitness costs and diversity of the cytotoxic T lymphocyte (CTL) response determine the rate of CTL escape during acute and chronic phases of HIV infection. J Virol (2011) 1.57

Identification of sequential viral escape mutants associated with altered T-cell responses in a human immunodeficiency virus type 1-infected individual. J Virol (2003) 1.57

In vivo CD8+ T-cell suppression of siv viremia is not mediated by CTL clearance of productively infected cells. PLoS Pathog (2010) 1.48

Relationship between functional profile of HIV-1 specific CD8 T cells and epitope variability with the selection of escape mutants in acute HIV-1 infection. PLoS Pathog (2011) 1.42

Demographic processes affect HIV-1 evolution in primary infection before the onset of selective processes. J Virol (2011) 1.41

Productive human immunodeficiency virus type 1 infection in peripheral blood predominantly takes place in CD4/CD8 double-negative T lymphocytes. J Virol (2007) 1.36

Epitope escape mutation and decay of human immunodeficiency virus type 1-specific CTL responses. J Immunol (2003) 1.36

HLA-associated clinical progression correlates with epitope reversion rates in early human immunodeficiency virus infection. J Virol (2008) 1.13

Modelling the evolution and spread of HIV immune escape mutants. PLoS Pathog (2010) 1.06

Precise identification of a human immunodeficiency virus type 1 antigen processing mutant. J Virol (2006) 1.02

HIV-1-specific CD4(+) responses in primary HIV-1 infection predict disease progression. AIDS (2014) 0.97

An unanticipated lack of consensus cytotoxic T lymphocyte epitopes in HIV-1 databases: the contribution of prediction programs. AIDS (2008) 0.97

Virological and immunological factors associated with HIV-1 differential disease progression in HLA-B 58:01-positive individuals. J Virol (2011) 0.96

Phylogenetic analysis consistent with a clinical history of sexual transmission of HIV-1 from a single donor reveals transmission of highly distinct variants. Retrovirology (2011) 0.89

Cytotoxic T-lymphocyte escape mutations identified by HLA association favor those which escape and revert rapidly. J Virol (2012) 0.85

The evolutionary selective advantage of HIV-1 escape variants and the contribution of escape to the HLA-associated risk of AIDS progression. PLoS One (2008) 0.83

Integrating genealogical and dynamical modelling to infer escape and reversion rates in HIV epitopes. Proc Biol Sci (2013) 0.80